HopeStage
Back to all studies
RecruitingNCT04996433

Comparing two psychotherapies for persistent depression in hospitalized patients

About this titleRead the official source — NCT04996433
Medication studyAges 18–75Germany
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 75 years.

Listed locations
Berlin and 7 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 1, 2021
Recruitment status
Recruiting
Enrollment listed in the registry
396
Sponsor
University of Greifswald
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Not clearly listed
Locations
Germany
Age range
From 18 Years to 75 Years
Official registry ID
NCT04996433
Official title
Show the full official title

Cognitive Behavioral Analysis System of Psychotherapy (CBASP) vs. Behavioral Activation (BA) in Persistently Depressed Treatment-resistant Inpatients: Efficacy, Moderators, and Mediators of Change

Recruitment & locations

Currently recruiting

Berlin · Bonn · Hanover

5 more locations
  • Jena
  • Lübeck
  • Marburg
  • München
  • Tübingen
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Greifswald, a university.

Does this study involve medication?

Yes. The study involves medication, including algorithm-based study medication.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies